Virtual Library
Start Your Search
- Virtual Library Home
- IASLC Library
- Explore Event
-
WCLC 2013
15th World Conference on Lung Cancer
Access to all presentations that occurred during the 15th World Conference on Lung Cancer in Sydney, Australia.
Presentation Date(s):- October 27 - 30, 2013
- Total Presentations: 2517
-
+
CALC - Chinese Alliance Against Lung Cancer Session
- Type: Other Sessions
- Track: Other Topics
- Presentations: 15
-
+
G01 - Progress in Lung Cancer: Celebrating 40 Years of IASLC and Research Progress
- Type: Other Sessions
- Track: Other Topics
- Presentations: 4
- Moderators:T. Mok
- Coordinates: 10/27/2013, 17:30 - 18:30, Parkside Auditorium, Level 1
-
+
G01.1 - Surgery and Staging
17:30 - 17:45 | Author(s): H. Asamura
- Abstract
Loading... -
+
G01.2 - Early Detection, Etiology, Epidemiology, Pulmonology and Radiology
17:45 - 18:00 | Author(s): P.E. Postmus
- Abstract
Loading... -
+
G01.3 - Biology and Pathology
18:00 - 18:15 | Author(s): F. Hirsch
- Abstract
No abstract available for this presentation
-
+
G01.4 - Non-Surgical Therapy
18:15 - 18:30 | Author(s): P.A. Bunn, Jr.
- Abstract
Loading...
-
+
PL02 - Will Personalised Therapies Ever “Cure” Metastatic NSCLC?
- Type: Plenary Session
- Track: Medical Oncology
- Presentations: 5
- Moderators:D. Gandara
- Coordinates: 10/28/2013, 08:15 - 09:45, Plenary Hall, Ground Level
-
+
PL02.4 - What is Cure and How Can We Achieve This With Targeted Therapies?
09:20 - 09:40 | Author(s): T. Mok
- Abstract
No abstract available for this presentation
-
+
P1.21 - Poster Session 1 - Diagnosis and Staging
- Type: Poster Session
- Track: Prevention & Epidemiology
- Presentations: 9
- Coordinates: 10/28/2013, 09:30 - 16:30, Exhibit Hall, Ground Level
-
+
P1.21-002 - A survey of EGFR mutation frequency and testing practices in Asia Pacific
09:30 - 09:30 | Author(s): Y. Yatabe
- Abstract
Loading...
-
+
O01 - Prognostic and Predictive Biomarkers I
- Type: Oral Abstract Session
- Track: Medical Oncology
- Presentations: 8
- Moderators:T. Mitsudomi
- Coordinates: 10/28/2013, 10:30 - 12:00, Parkside Auditorium, Level 1
-
+
O01.06 - Dynamic change in plasma EGFR mutation DNA in response to first line therapy for advanced stage non-small cell lung cancer (NSCLC)
11:25 - 11:35 | Author(s): T. Mok
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
MO07 - NSCLC - Targeted Therapies II
- Type: Mini Oral Abstract Session
- Track: Medical Oncology
- Presentations: 14
- Moderators:T. John
- Coordinates: 10/28/2013, 16:15 - 17:45, Bayside Auditorium B, Level 1
-
+
MO07.13 - Efficacy of afatinib vs. chemotherapy in treatment-naïve patients with non-small cell lung cancer (NSCLC) harbouring activating EGFR mutations with or without metastatic brain disease
17:25 - 17:30 | Author(s): M. Schuler
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
P2.11 - Poster Session 2 - NSCLC Novel Therapies
- Type: Poster Session
- Track: Medical Oncology
- Presentations: 46
- Coordinates: 10/29/2013, 09:30 - 16:30, Exhibit Hall, Ground Level
-
+
P2.11-041 - Effect of treatment duration on incidence of adverse events (AEs) in a phase III study of crizotinib versus chemotherapy in advanced ALK-positive non-small cell lung cancer (NSCLC)
09:30 - 09:30 | Author(s): A.T. Shaw
- Abstract
Loading...
-
+
MO12 - Prognostic and Predictive Biomarkers III
- Type: Mini Oral Abstract Session
- Track: Medical Oncology
- Presentations: 12
- Moderators:B. Han
- Coordinates: 10/29/2013, 10:30 - 12:00, Parkside Ballroom B, Level 1
-
+
MO12.07 - The prevalence of MET expression by immunohistochemistry (IHC) in the MetLung (OAM4971g) trial: a randomized, placebo-controlled, phase III study with erlotinib + onartuzumab (MetMAb) vs erlotinib + placebo in patients with previously treated non-small cell lung cancer (NSCLC)
11:10 - 11:15 | Author(s): M.J. Edelman
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
P3.11 - Poster Session 3 - NSCLC Novel Therapies
- Type: Poster Session
- Track: Medical Oncology
- Presentations: 52
- Coordinates: 10/30/2013, 09:30 - 16:30, Exhibit Hall, Ground Level
-
+
P3.11-023 - Comparative safety profile of afatinib in Asian and non-Asian patients with EGFR mutation-positive (EGFR M+) non-small cell lung cancer (NSCLC)
09:30 - 09:30 | Author(s): L.V. Sequist
- Abstract
Loading...
-
+
PL05 - Genomics: From Research Tool to the Lung Cancer Clinic
- Type: Plenary Session
- Track: Pathology
- Presentations: 5
- Moderators:P. Goldstraw
- Coordinates: 10/30/2013, 16:15 - 17:45, Plenary Hall, Ground Level
-
+
PL05.0 - N/A - Chair Intro
16:15 - 16:20
- Abstract
No abstract available for this presentation
-
+
PL05.1 - Implications of the Lung Cancer Genome Sequencing
16:20 - 16:45 | Author(s): R. Govindan
- Abstract
No abstract available for this presentation
-
+
PL05.2 - Challenges in Bioinformatics
16:45 - 17:10 | Author(s): Y. Shyr
- Abstract
No abstract available for this presentation
-
+
PL05.3 - Challenges for the Clinician
17:10 - 17:35 | Author(s): S. Devarakonda
- Abstract
Loading... -
+
PL05.4 - Closing Remarks and Invitation to Denver, 2015
17:35 - 17:45
- Abstract
No abstract available for this presentation
